ASLAN Pharmaceuticals

You are now leaving our web site.
I understand

Publications & Posters

Webcast and Presentations R&D Day 2022

In September 2022, ASLAN hosted an R&D Day on eblasakimab featuring Key Opinion Leaders Peter Lio MD (Northwestern University) and Shawn Kwatra MD PhD (Johns Hopkins University). To access the presentation materials, please follow this link.

ASLAN’s A4 webinar series: Aspects of Atopic Dermatitis and ASLAN004 (eblasakimab)

We hosted a series of dialogues with key opinion leaders in dermatology on the emerging Atopic Dermatitis (AD) landscape and ASLAN004 (eblasakimab). To request access to replays of the episodes from the A4 Series, please follow this link.